Ani Pharmaceuticals Inc (ANIP)

Cost of Revenue

$100.16M

Quarterly · Period ending: · USD

ANIP logo

ANIP Cost of Revenue

Latest reported$100.16M
ANIP Quarterly Cost of Revenue ($0.00 → $100.16M)
High-resolution chart · PNG

ANIP cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ani Pharmaceuticals Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.